Publications by authors named "Layton Woolford"

Claim this Profile
H
HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans.
Yuanqing Ma, Allison Joyce, Olivia Brandenburg, Faeze Saatchi, Christina Stevens, Layton Woolford

Clin Cancer Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ImmunoPET Imaging with 89Zr-Labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma.
Aditi Mulgaonkar, Roy Elias, Layton Woolford, Bing Guan, Kien Nham

Clin Cancer Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A renal cell carcinoma tumorgraft platform to advance precision medicine.
Roy Elias, Vanina T Tcheuyap, Akash K Kaushik, Nirmish Singla, Ming Gao, Layton Woolford

Cell Rep· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of renal cell carcinoma invasion and metastatic competence.
Kangsan Kim, Qinbo Zhou, Alana Christie, Christina Stevens, Yuanqing Ma, Layton Woolford

Nat Commun· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement as Prognostic Biomarker and Potential Therapeutic Target in Renal Cell Carcinoma.
Britney Reese, Ashok Silwal, Elizabeth Daugherity, Michael Daugherity, Mahshid Arabi, Layton Woolford

J Immunol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor, in Patients with Clear Cell Renal Cell Carcinoma.
Kevin D Courtney, Yuanqing Ma, Alberto Diaz de Leon, Alana Christie, Zhiqun Xie, Layton Woolford

Clin Cancer Res· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 detection using Zr-atezolizumab immuno-PET in renal cell carcinoma tumorgrafts from a patient with favorable nivolumab response.
Joseph Vento, Aditi Mulgaonkar, Layton Woolford, Kien Nham, Alana Christie

J Immunother Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis